Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials (2019)

First Author: Johnson D
Attributed to:  Renewal of the Network of Hubs for Trials Methodology Research. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/jpm9030042

PubMed Identifier: 31480618

Publication URI: http://europepmc.org/abstract/MED/31480618

Type: Journal Article/Review

Parent Publication: Journal of Personalized Medicine

Issue: 3

ISSN: 2075-4426